Elsevier

Toxicology Reports

Volume 2, 2015, Pages 1423-1433
Toxicology Reports

Effects of 4-nonylphenol on oxidant/antioxidant balance system inducing hepatic steatosis in male rat

https://doi.org/10.1016/j.toxrep.2015.10.006Get rights and content
Under a Creative Commons license
open access

Highlights

  • Intraperitoneal administration of 4-NP induces hepatic steatosis in male Sprague-Dawley rats.

  • Hepatocytes apoptosis is highly implicated in the occurrence and development of NAFLD.

  • Hepatic mitochondrial disturbance promotes deleterious consequences, such as OS and accumulation of triglycerides (steatosis).

Abstract

An emerging literature suggests that early life exposure to 4-nonylphenol (4-NP), a widespread endocrine disrupting chemical, may increase the risk of metabolic syndrome. In this study, we investigated the hypothesis that intraperitoneal administration of 4-NP induces hepatic steatosis in rat. 24 male Sprague-Dawley rats were administered with 4-NP (0, 2, 10 and 50 mg/kg b.wt) in corn oil for 30 days. Liver histology, biochemical analysis and gene expression profiling were examined. After treatment, abnormal liver morphology and function were observed in the 4-NP-treated rat, and significant changes in gene expression an indicator of hepatic steatosis and apoptosis were observed compared with controls. Up-regulated genes involved in apoptosis, hepatotoxity and oxidative stress, increased ROS and decrease of antioxidant enzyme were observed in the 4-NP exposed rat. Extensive fatty accumulation in liver section and elevated serum GOT, GPT, LDH and γ-GT were also observed. Incidence and severity of liver steatosis was scored and taken into consideration (steatosis, ballooning and lobular inflammation). Hepatocytes apoptosis could promote NAFLD progression; Fas/FasL, TNF-α and Caspase-9 mRNA activation were important contributing factors to hepatic steatosis. These findings provide the first evidence that 4-NP affects the gene expression related to liver hepatotoxicity, which is correlated with hepatic steatosis.

Abbreviations

APNEIs
alkylphenol polyethoxylates
4-NP
4-nonylphenol
FAO
fatty acid oxidation
ROS
reactive oxygen species
Cyt c
cytochrome c
NAFLD
nonalcoholic fatty liver disease
NASH
non-alcoholic hepatic steatosis
OS
oxidative stress
GOT
glutamic-oxalacetic transaminase
GPT
glutamate pyruvate transaminase
γ-GT
gamma glutamyltransferase
LDH
lactate dehydrogenase
AhR
aril hydrocarbon receptor
PPAR
peroxisome proliferation-activated receptor
TAG
triacylglycerol
FFA
free fatty acid
HSC
hepatic stellate cell
IR
insulin resistance

Chemical compounds studied in this article

4-Nonylphenol (PubChem CID: 1752)
Xylene (PubChem CID: 6850715)
Aprotinin (PubChem CID: 22833874)
Bouin's fluid (PubChem CID: 124013)
Hematoxylin Eosin (PubChem CID: 86598188)
Trizol (PubChem CID: 378478)
Superoxide (PubChem CID: 5359597)
Malondialdehyde (PubChem CID: 10964)
Hydrogen peroxide (PubChem CID: 784)
Diamninobenzidine Tetrahydrochloride (PubChem CID: 23892)
Collagenase (PubChem CID: 5046512)
Tromethamine (Tris) (PubChem CID: 6503)
Sodium chloride (PubChem CID: 5234)
Phenylmethylsulfonyl fluoride (PubChem CID: 4784)
Nitrotetrazolium Blue chloride (PubChem CID: 9281)
Thiobarbituric Acid (PubChem CID: 2723628)

Keywords

4-Nonylphenol
Hepatic steatosis
Oxidative stress
Genes
Liver
Apoptosis

Cited by (0)